Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis

Current therapy for leishmaniasis is unsatisfactory because parenteral antimonial salts and pentamidine are associated with significant toxicity and failure rates. We examined the efficacy of KY62, a new, water-soluble, polyene antifungal, against cutaneous infection with Leishmania amazonensis and...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Al-Abdely, Hail M., Graybill, John R., Bocanegra, Rosie, Najvar, Laura, Montalbo, Eleanor, Regen, Steven L., Melby, Peter C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105886/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756753/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2542
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!